Monica Tolazzi
- Virology top 5%
- HIV Research and Treatment 14
- Infectious Diseases top 5%
- HIV/AIDS drug development and treatment 3
- HIV/AIDS Research and Interventions 2
- Microbiology top 5%
-
- Immune Cell Function and Interaction 3
- Immunotherapy and Immune Responses 2
- Modeling and Simulation top 10%
-
- vaccines and immunoinformatics approaches 3
-
- Monoclonal and Polyclonal Antibodies Research 3
-
- Herpesvirus Infections and Treatments 2
- Co-authors
- Francesca SironiLia VassenaPaolo LussoLucinda FurciGabriella ScarlattiStefania DispinseriLorenzo PiemontiMassimiliano Secchi
- Partner nations
- ItalyUnited StatesUnited Kingdom
In The Last Decade
Monica Tolazzi
15 papers receiving 497 citations
Hit Papers
Peers
Comparison fields: 5 of 56
- Virology 164
- Infectious Diseases 279
- Microbiology 78
- Immunology 134
- Modeling and Simulation 22
Countries citing papers authored by Monica Tolazzi
This map shows the geographic impact of Monica Tolazzi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Monica Tolazzi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Monica Tolazzi more than expected).
Fields of papers citing papers by Monica Tolazzi
This network shows the impact of papers produced by Monica Tolazzi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Monica Tolazzi. The network helps show where Monica Tolazzi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Monica Tolazzi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2022 | 2 | |
| 3 | 2022 | 1 | |
| 4 | The path towards an HIV vaccine. | 2022 | 4 |
| 5 | Neutralizing antibody responses to SARS-CoV-2 in symptomatic COVID-19 is persistent and critical for survivalbreakdown → | 2021 | 222 |
| 6 | 2021 | 15 | |
| 7 | 2021 | 1 | |
| 8 | 2020 | 3 | |
| 9 | 2018 | 33 | |
| 10 | 2016 | 10 | |
| 11 | 2016 | 6 | |
| 12 | 2015 | 10 | |
| 13 | 2014 | 3 | |
| 14 | 2012 | 71 | |
| 15 | 2012 | 31 | |
| 16 | 2006 | 89 | |
| 17 | 2005 | 1 |
About Monica Tolazzi
Monica Tolazzi is a scholar working on Virology, Immunology and Microbiology, having authored 17 papers that have together received 502 indexed citations. Recurring topics across this work include HIV Research and Treatment (14 papers), vaccines and immunoinformatics approaches (3 papers), HIV/AIDS drug development and treatment (3 papers), Immune Cell Function and Interaction (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Herpesvirus Infections and Treatments (2 papers), HIV/AIDS Research and Interventions (2 papers) and Immunotherapy and Immune Responses (2 papers). The work is most often cited by research in Virology (164 citations), Infectious Diseases (279 citations) and Microbiology (78 citations). Monica Tolazzi has collaborated with scholars based in Italy, United States and United Kingdom. Frequent co-authors include Francesca Sironi, Lia Vassena, Paolo Lusso, Lucinda Furci, Gabriella Scarlatti, Stefania Dispinseri, Lorenzo Piemonti, Massimiliano Secchi, Vito Lampasona and Cristina Brigatti. Their work appears in journals such as Nature Communications, Blood and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.